Surgical treatment of age-related macular degeneration

Seminars in Ophthalmology

Volumn 26, Issue 3, 2011, Pages 181-191

  Skaf, Ayham R ^a   Mahmoud, Tahmer ^a  

^a WAYNE STATE UNIVERSITY   (United States)

Author keywords

choroidal neovascularization; geographic atrophy; macular translocation; RPE transplantation; submacular hemorrhage; submacular surgery

Indexed keywords

BEVACIZUMAB; TISSUE PLASMINOGEN ACTIVATOR;

APHAKIA; AUTOFLUORESCENCE; BEST CORRECTED VISUAL ACUITY; BRUCH MEMBRANE; CATARACT; CELL SUSPENSION; DISEASE COURSE; EPIRETINAL MEMBRANE; EXUDATIVE MACULAR DEGENERATION; FOLLOW UP; FULL RETINA MACULA TRANSLOCATION; GEOGRAPHIC ATROPHY; GLAUCOMA; GOLD STANDARD; HUMAN; INDOCYANINE GREEN ANGIOGRAPHY; INTERMETHOD COMPARISON; IRON OVERLOAD; LASER COAGULATION; LENSECTOMY; LIMITED RETINA MACULA TRANSLOCATION; META ANALYSIS (TOPIC); MULTICENTER STUDY (TOPIC); NEOVASCULAR GLAUCOMA; OPTICAL COHERENCE TOMOGRAPHY; PHOTODYNAMIC THERAPY; PHOTORECEPTOR; PIGMENT EPITHELIUM; PIGMENT EPITHELIUM TRANSPLANTATION; POSTOPERATIVE COMPLICATION; POSTOPERATIVE PERIOD; PREOPERATIVE PERIOD; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL (TOPIC); RECURRENT DISEASE; REOPERATION; RETINA DEGENERATION; RETINA DETACHMENT; RETINA FLUORESCEIN ANGIOGRAPHY; RETINA FOVEA; RETINA HEMORRHAGE; RETINA MACULA AGE RELATED DEGENERATION; RETINA MACULA EDEMA; RETINA MACULA TRANSLOCATION; RETINA SURGERY; RETINOTOMY; REVIEW; SCAR FORMATION; SUBMACULAR SURGERY; SUBRETINAL NEOVASCULARIZATION; TISSUE TRANSPLANTATION; TREATMENT INDICATION; VISION; VISUAL ACUITY; VITRECTOMY; VITREORETINOPATHY; VITREOUS HEMORRHAGE;

CHOROIDAL NEOVASCULARIZATION; HUMANS; MACULAR DEGENERATION; OPHTHALMOLOGIC SURGICAL PROCEDURES; TREATMENT OUTCOME; VISUAL ACUITY;

EID: 79957625721     PISSN: 08820538     EISSN: 17445205     Source Type: Journal    
DOI: 10.3109/08820538.2011.577133     Document Type: Review

References (68)

1. Klein R, Klein BE, Jensen SC, Meuer SM. The five-year incidence and progression of age-related maculopathy: The Beaver Dam Eye Study. Ophthalmology. Jan 1997;104(1):7-21. (Pubitemid 27081937)
2. Bressler NM, Bressler SB, Fine SL. Age-related macular degeneration.Surv Ophthalmol. May-Jun 1988;32(6):375-413.
3. Macular Photocoagulation Study Group. Laser photocoagulation of subfoveal neovascular lesions in age-related macular degeneration. Results of a randomized clinical trial. Arch Ophthalmol. Sep 1991;109(9):1220-1231.
4. de Juan E, Jr., Machemer R. Vitreous surgery for hemorrhagic and fibrous complications of age-related macular degeneration. Am J Ophthalmol. Jan 15 1988;105(1):25-29. (Pubitemid 18021339)
5. Thomas MA, Grand MG, Williams DF, Lee CM, Pesin SR, Lowe MA. Surgical management of subfoveal choroidal neovascularization. Ophthalmology. Jun 1992;99(6):952-968; discussion 975-956.
6. Berger AS, Kaplan HJ. Clinical experience with the surgical removal of subfoveal neovascular membranes. Short-term postoperative results. Ophthalmology. Jun 1992;99(6):969-975; discussion 975-966.
7. Sabates FN, Fletcher DC. Surgical excision of subfoveal neovascular membranes in age-related macular degeneration. Am J Ophthalmol. Aug 15 1992;114(2):241-242.
8. Lambert HM, Capone A, Jr., Aaberg TM, Sternberg P, Jr., Mandell BA, Lopez PF. Surgical excision of subfoveal neovascular membranes in age-related macular degeneration. Am J Ophthalmol. Mar 15 1992;113(3):257-262.
9. Krasnov MM, Stolyarenko GE. Surgical management of exudative maculopathies: Preliminary report. Eur J Ophthalmol. Jul-Sep 1992;2(3):122-128.
10. Falkner C, Leitich H, Frommlet F, Bauer P, Binder S. The end of submacular surgery for age-related macular degeneration? A meta-analysis. Graefe's Archive for Clinical and Experimental Ophthalmology. 2007;245(4):490-501. (Pubitemid 46485251)
11. Lewis H, VanderBrug Medendorp S. Tissue plasminogen activator-assisted surgical excision of subfoveal choroidal neovascularization in age-related macular degeneration: A randomized, double-masked trial. Ophthalmology. Nov 1997;104(11):1847-1851; discussion 1852.
12. Bressler NM, Bressler SB, Hawkins BS, Marsh MJ, Sternberg P, Jr., Thomas MA. Submacular surgery trials randomized pilot trial of laser photocoagulation versus surgery for recurrent choroidal neovascularization secondary to age-related macular degeneration: I. Ophthalmic outcomes submacular surgery trials pilot study report number 1. Am J Ophthalmol. Oct 2000;130(4):387-407.
13. Hawkins BS, Bressler NM, Miskala PH, et al. Surgery for subfoveal choroidal neovascularization in age-related macular degeneration: Ophthalmic findings: SST report no.
14. Ophthalmology. Nov 2004;111(11):1967-1980.
15. Bressler NM, Bressler SB, Childs AL, et al. Surgery for hemorrhagic choroidal neovascular lesions of age-related macular degeneration: Ophthalmic findings: SST report no.
16. Ophthalmology. Nov 2004;111(11):1993-2006.
17. Machemer R, Steinhorst UH. Retinal separation, retinotomy, and macular relocation: II. A surgical approach for age-related macular degeneration? Graefes Arch Clin Exp Ophthalmol. Nov 1993;231(11):635-641. (Pubitemid 23342235)
18. Ninomiya Y, Lewis JM, Hasegawa T, Tano Y. Retinotomy and foveal translocation for surgical management of subfoveal choroidal neovascular membranes. Am J Ophthalmol. Nov 1996;122(5):613-621. (Pubitemid 26371369)
19. de Juan E, Jr., Loewenstein A, Bressler NM, Alexander J. Translocation of the retina for management of subfoveal choroidal neovascularization II: A preliminary report in humans. Am J Ophthalmol. May 1998;125(5):635-646. (Pubitemid 28265512)
20. Pieramici DJ, De Juan E, Jr., Fujii GY, et al. Limited inferior macular translocation for the treatment of subfoveal choroidal neovascularization secondary to age-related macular degeneration. Am J Ophthalmol. Oct 2000;130(4):419-428.
21. Toth CA, Freedman SF. Macular translocation with 360- degree peripheral retinectomy impact of technique and surgical experience on visual outcomes. Retina. 2001;21(4):293-303. (Pubitemid 32769241)
22. Abdel-Meguid A, Lappas A, Hartmann K, et al. One year follow up of macular translocation with 360 degree retinotomy in patients with age related macular degeneration. Br J Ophthalmol. May 2003;87(5):615-621. (Pubitemid 36535337)
23. Pertile G, Claes C. Macular translocation with 360 degree retinotomy for management of age-related macular degeneration with subfoveal choroidal neovascularization. Am J Ophthalmol. Oct 2002;134(4):560-565. (Pubitemid 35304646)
24. Eckardt C, Eckardt U, Conrad HG. Macular rotation with and without counter-rotation of the globe in patients with age-related macular degeneration. Graefes Arch Clin Exp Ophthalmol. Apr 1999;237(4):313-325. (Pubitemid 29145810)
25. Aisenbrey S, Lafaut BA, Szurman P, et al. Macular translocation with 360 degrees retinotomy for exudative age-related macular degeneration. Arch Ophthalmol. Apr 2002;120(4):451-459. (Pubitemid 34727816)
26. Mruthyunjaya P, Stinnett SS, Toth CA. Change in visual function after macular translocation with 360 degrees retinectomy for neovascular age-related macular degeneration. Ophthalmology. Sep 2004;111(9):1715-1724. (Pubitemid 39179688)
27. Toth CA, Lapolice DJ, Banks AD, Stinnett SS. Improvement in near visual function after macular translocation surgery with 360-degree peripheral retinectomy. Graefes Arch Clin Exp Ophthalmol. Jul 2004;242(7):541-548. (Pubitemid 39157681)
28. Gelisken F, Voelker M, Schwabe R, et al. Full macular translocation versus photodynamic therapy with verteporfin in the treatment of neovascular age-related macular degeneration: 1-year results of a prospective, controlled, randomised pilot trial (FMT-PDT). Graefes Arch Clin Exp Ophthalmol. Aug 2007;245(8):1085-1095. (Pubitemid 47034332)
29. Luke M, Ziemssen F, Volker M, et al. Full macular translocation (FMT) versus photodynamic therapy (PDT) with verteporfin in the treatment of neovascular age-related macular degeneration: 2-year results of a prospective, controlled, randomised pilot trial (FMT-PDT). Graefes Arch Clin Exp Ophthalmol. Jun 2009;247(6):745-754.
30. Peyman GA, Blinder KJ, Paris CL, Alturki W, Nelson NC, Jr., Desai U. A technique for retinal pigment epithelium transplantation for age-related macular degeneration secondary to extensive subfoveal scarring. Ophthalmic Surg. Feb 1991;22(2):102-108.
31. Algvere PV, Berglin L, Gouras P, Sheng Y. Transplantation of fetal retinal pigment epithelium in age-related macular degeneration with subfoveal neovascularization. Graefes Arch Clin Exp Ophthalmol. Dec 1994;232(12):707-716.
32. Algvere PV, Berglin L, Gouras P, Sheng Y, Kopp ED. Transplantation of RPE in age-related macular degeneration: Observations in disciform lesions and dry RPE atrophy. Graefes Arch Clin Exp Ophthalmol. Mar 1997;235(3):149-158. (Pubitemid 27132396)
33. Thumann G, Aisenbrey S, Schraermeyer U, et al. Transplantation of autologous iris pigment epithelium after removal of choroidal neovascular membranes. Arch Ophthalmol. Oct 2000;118(10):1350-1355.
34. Binder S, Stolba U, Krebs I, et al. Transplantation of autologous retinal pigment epithelium in eyes with foveal neovascularization resulting from age-related macular degeneration: A pilot study. Am J Ophthalmol. Feb 2002;133(2):215-225. (Pubitemid 34072050)
35. Falkner-Radler CI, Krebs I, Glittenberg C, et al. Human retinal pigment epithelium (RPE) transplantation: Outcome after autologous RPE-choroid sheet and RPE cell-suspension in a randomised clinical study. Br J Ophthalmol. Mar 2011;95(3):370-5.
36. MacLaren RE, Bird AC, Sathia PJ, Aylward GW. Long-term results of submacular surgery combined with macular translocation of the retinal pigment epithelium in neovascular age-related macular degeneration. Ophthalmology. Dec 2005;112(12):2081-2087. (Pubitemid 41720984)
37. Fine HF, Iranmanesh R, Del Priore LV, et al. Surgical outcomes after massive subretinal hemorrhage secondary to age-related macular degeneration. Retina. Nov-Dec;30(10):1588-1594.
38. Kuhli-Hattenbach C, Fischer IB, Schalnus R, Hattenbach LO. Subretinal hemorrhages associated with age-related macular degeneration in patients receiving anticoagulation or antiplatelet therapy. Am J Ophthalmol. Feb;149(2):316-321 e311.
39. Scupola A, Coscas G, Soubrane G, Balestrazzi E. Natural history of macular subretinal hemorrhage in age-related macular degeneration. Ophthalmologica. 1999;213(2):97-102. (Pubitemid 29049394)
40. Hassan AS, Johnson MW, Schneiderman TE, et al. Management of submacular hemorrhage with intravitreous tissue plasminogen activator injection and pneumatic displacement. Ophthalmology. Oct 1999;106(10):1900-1906; discussion 1906-1907.
41. Peyman GA, Nelson NC, Jr., Alturki W, et al. Tissue plasminogen activating factor assisted removal of subretinal hemorrhage. Ophthalmic Surg. Oct 1991;22(10):575-582.
42. Ron Y, Ehrlich R, Axer-Siegel R, Rosenblatt I, Weinberger D. Pneumatic displacement of submacular hemorrhage due to age-related macular degeneration. Ophthalmologica. 2007;221(1):57-61. (Pubitemid 46023411)
43. Gopalakrishan M, Giridhar A, Bhat S, Saikumar SJ, Elias A, N S. Pneumatic displacement of submacular hemorrhage: Safety, efficacy, and patient selection. Retina. Mar 2007;27(3):329-334. (Pubitemid 46402867)
44. Hesse L, Schmidt J, Kroll P. Management of acute submacular hemorrhage using recombinant tissue plasminogen activator and gas. Graefes Arch Clin Exp Ophthalmol. Apr 1999;237(4):273-277. (Pubitemid 29145803)
45. Hattenbach LO, Klais C, Koch FH, Gumbel HO. Intravitreous injection of tissue plasminogen activator and gas in the treatment of submacular hemorrhage under various conditions. Ophthalmology. Aug 2001;108(8):1485-1492. (Pubitemid 32709042)
46. Chen CY, Hooper C, Chiu D, Chamberlain M, Karia N, Heriot WJ. Management of submacular hemorrhage with intravitreal injection of tissue plasminogen activator and expansile gas. Retina. Mar 2007;27(3):321-328. (Pubitemid 46398897)
47. Tsai SC, Lin JM, Chen HY. Intravitreous recombinant tissue plasminogen activator and gas to treat submacular hemorrhage in age-related macular degeneration. Kaohsiung J Med Sci. Dec 2003;19(12):608-616.
48. Haupert CL, McCuen BW, 2nd, Jaffe GJ, et al. Pars plana vitrectomy, subretinal injection of tissue plasminogen activator, and fluid-gas exchange for displacement of thick submacular hemorrhage in age-related macular degeneration. Am J Ophthalmol. Feb 2001;131(2):208-215. (Pubitemid 32157035)
49. Olivier S, Chow DR, Packo KH, MacCumber MW, Awh CC. Subretinal recombinant tissue plasminogen activator injection and pneumatic displacement of thick submacular hemorrhage in age-related macular degeneration. Ophthalmology. Jun 2004;111(6):1201-1208. (Pubitemid 38737001)
50. Singh RP, Patel C, Sears JE. Management of subretinal macular haemorrhage by direct administration of tissue plasminogen activator. Br J Ophthalmol. Apr 2006;90(4):429-431.
51. Vander JF, Federman JL, Greven C, Slusher MM, Gabel VP. Surgical removal of massive subretinal hemorrhage associated with age-related macular degeneration. Ophthalmology. Jan 1991;98(1):23-27.
52. Ibanez HE, Williams DF, Thomas MA, et al. Surgical management of submacular hemorrhage. A series of 47 consecutive cases. Arch Ophthalmol. Jan 1995;113(1):62-69.
53. Kamei M, Misono K, Lewis H. A study of the ability of tissue plasminogen activator to diffuse into the subretinal space after intravitreal injection in rabbits. Am J Ophthalmol. Dec 1999;128(6):739-746. (Pubitemid 30001770)
54. Hillenkamp J, Surguch V, Framme C, Gabel VP, Sachs HG. Management of submacular hemorrhage with intravitreal versus subretinal injection of recombinant tissue plasminogen activator. Graefes Arch Clin Exp Ophthalmol. Jan 2010;248(1):5-11.
55. Kamei M, Tano Y. Tissue plasminogen activator-assisted vitrectomy: surgical drainage of submacular hemorrhage. Dev Ophthalmol. 2009;44:82-88.
56. Shah SP, Hubschman JP, Gonzales CR, Schwartz SD. Submacular combination treatment for management of acute, massive submacular hemorrhage in age-related macular degeneration. Ophthalmic Surg Lasers Imaging. May-Jun 2009;40(3):308-315.
57. Guthoff R, Guthoff T, Meigen T, Goebel W. Intravitreous Injection of bevacizumab, tissue plasminogen activator, and gas in the treatment of submacular hemorrhage in age-related macular degeneration. Retina. Jan 2011;31(1):36-40.
58. Klein R, Wang Q, Klein BE, Moss SE, Meuer SM. The relationship of age-related maculopathy, cataract, and glaucoma to visual acuity. Invest Ophthalmol Vis Sci. Jan 1995;36(1):182-191.
59. Algvere PV, Gouras P, Dafgard Kopp E. Long-term outcome of RPE allografts in non-immunosuppressed patients with AMD. Eur J Ophthalmol. Jul-Sep 1999;9(3):217-230. (Pubitemid 29493608)
60. Joussen AM, Joeres S, Fawzy N, et al. Autologous translocation of the choroid and retinal pigment epithelium in patients with geographic atrophy. Ophthalmology. Mar 2007;114(3):551-560. (Pubitemid 46282952)
61. Eckardt C, Eckardt U. Macular translocation in nonexudative age-related macular degeneration. Retina. Dec 2002;22(6):786-794. (Pubitemid 35462511)
62. Cahill MT, Mruthyunjaya P, Bowes Rickman C, Toth CA. Recurrence of retinal pigment epithelial changes after macular translocation with 360 degrees peripheral retinectomy for geographic atrophy. Arch Ophthalmol. Jul 2005;123(7):935-938. (Pubitemid 41057990)
63. Khurana RN, Fujii GY, Walsh AC, Humayun MS, de Juan E, Jr., Sadda SR. Rapid recurrence of geographic atrophy after full macular translocation for nonexudative age-related macular degeneration. Ophthalmology. Sep 2005;112(9):1586-1591. (Pubitemid 41725417)
64. Brown DM, Michels M, Kaiser PK, Heier JS, Sy JP, Ianchulev T. Ranibizumab versus verteporfin photodynamic therapy for neovascular age-related macular degeneration: Twoyear results of the ANCHOR study. Ophthalmology. Jan 2009;116(1):57-65 e55.
65. Rosenfeld PJ, Brown DM, Heier JS, et al. Ranibizumab for neovascular age-related macular degeneration. N Engl J Med. Oct 5 2006;355(14):1419-1431. (Pubitemid 44511557)
66. Lux A, Llacer H, Heussen FM, Joussen AM. Non-responders to bevacizumab (Avastin) therapy of choroidal neovascular lesions. Br J Ophthalmol. Oct 2007;91(10):1318-1322. (Pubitemid 47492865)
67. Haverbeke GM, Claes C. Full macular translocation for choroidal neovascularization in the era of intravitreal pharmacological therapy. Retina. Nov-Dec 2010;30(10):1739-1743.
68. Heriot WJ. Intravitreal gas and TPA: An outpatient procedure for submacular hemorrhage. Paper presented at AAO Annual Vitreoretinal Update, 1996, Chicago, Illinois.